Outcomes following I-131 treatment with cumulative dose exceeding or equal to 600 mCi in differentiated thyroid carcinoma patients

Autor:	Pawana Pusuwan, Chalermrat Kaewput
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	lcsh:Medical physics. Medical radiology. Nuclear medicine medicine.medical_specialty lcsh:R895-920 differentiated thyroid cancer Neutropenia Malignancy Gastroenterology 030218 nuclear medicine & medical imaging Papillary thyroid cancer Thyroid carcinoma 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Follicular thyroid cancer Cumulative dose business.industry radioiodine therapy medicine.disease Bone marrow suppression 030220 oncology & carcinogenesis cumulative dose Original Article business Progressive disease 600 mci
Zdroj:	World Journal of Nuclear Medicine, Vol 20, Iss 1, Pp 54-60 (2021) World Journal of Nuclear Medicine
ISSN:	1607-3312 1450-1147
Popis:	To evaluate treatment outcomes following radioactive iodine (RAI) treatment with a cumulative dose of ≥≥600 mCi in differentiated thyroid carcinoma (DTC) patients, a retrospective review of medical records was done in 176 DTC patients with a cumulative dose of ≥600 mCi from January 1993 to December 2013. All patients were followed up for at least 2 years after receiving 600 mCi of I-131 treatment. Remission criteria were no clinical and imaging evidence of disease and low serum thyroglobulin levels during thyroid-stimulating hormone suppression of
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::611a869846d6c1026b145ec6f6142c32 http://www.wjnm.org/article.asp?issn=1450-1147 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.